SGLT2 inhibitor treatment may now be considered in broader T2DM population
AHA 2018 - Chicago, IL, VS
3' education - Nov. 11, 2018 - Steve Wiviott, MD - Boston, MA, VS.Educational information
This video was recorded at the congress of the American Heart Association on November 10, 2018, in Chicago, IL, USA.
Faculty
Steve Wiviott, MD, Brigham and Women's Hospital, Boston, MA, VS.
Disclosures
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.
Share this page with your colleagues and friends: